India · Delayed Price · Currency is INR Rainbow Children's Medicare Earnings Call Transcripts
Fiscal Year 2026
-
Q4 FY26 saw record revenue and capacity addition, with 24% revenue growth and strong operational metrics. Over 900 beds are in the pipeline, all funded internally, and the company targets 20% growth in FY27 while maintaining margins.
-
Revenue grew 12% year-over-year in Q3 FY26, with strong performance from new and acquired hospitals. Occupancy was impacted by seasonality but is targeted to improve to 55-60% next year through operational and digital initiatives. EBITDA margin remained robust at 33%.
-
Q2 FY26 saw modest revenue and EBITDA growth amid seasonal softness, with strong specialty and IVF segment performance. Integration of new hospitals and upcoming expansions position the business for 20% CAGR growth, supported by robust margins and a strong balance sheet.
-
Revenue grew 7% YoY to INR 353 crores, with EBITDA up 11% and PAT up 35%. Expansion continued via acquisition and new projects, while mature hospitals saw muted volumes but strong specialty mix. Guidance remains for late teens to 20% revenue growth, with robust cash reserves and asset-light expansion.
Fiscal Year 2025
-
Q4 FY25 saw modest growth due to seasonality, but full-year revenue rose 16.9% and EBITDA 14.2% YoY. 250 new beds are planned for FY26, with EBITDA margin guidance at 25%+ and revenue CAGR expected in the high teens. IVF and specialty care are key growth drivers.
-
Q3 FY25 delivered 18.5% revenue growth and 14% EBITDA growth year-over-year, with strong performance from both mature and new hospitals. Expansion plans remain on track, though international business faces headwinds and new projects like Gurgaon will be asset-heavy.
-
Revenue, EBITDA, and PAT grew over 25% year-over-year in Q2, driven by strong performance in both mature and new hospitals, robust occupancy, and expansion of specialized services. The group maintains a strong balance sheet, is funding all growth internally, and is focused on further expansion in Bangalore and NCR.
-
Q1 FY25 saw 15% revenue growth and strong operational metrics, with new hospitals expanding capacity but impacting margins due to higher costs. Occupancy and patient volumes improved, and margin recovery is expected as new units ramp up and break even.